Works matching IS 00099236 AND DT 2024 AND VI 115 AND IP 5
Results: 31
Patient‐Centric Clinical Pharmacology: A Journey from Discovery to Recovery.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 5, p. 928, doi. 10.1002/cpt.3243
- By:
- Publication type:
- Article
ASCPT News.
- Published in:
- 2024
- Publication type:
- Proceeding
In This Issue.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 5, p. 915, doi. 10.1002/cpt.3233
- Publication type:
- Article
Highlights.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 5, p. 920, doi. 10.1002/cpt.3232
- Publication type:
- Article
Best Practices for Pharmacokinetic Studies of New Chemical Entities.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 5, p. 917, doi. 10.1002/cpt.3231
- By:
- Publication type:
- Article
Chinese Expert Consensus on the Clinical Diagnosis and Management of Statin Intolerance.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 5, p. 954, doi. 10.1002/cpt.3213
- By:
- Publication type:
- Article
Tepid Uptake of Digital Health Technologies in Clinical Trials by Pharmaceutical and Medical Device Firms.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 5, p. 988, doi. 10.1002/cpt.3192
- By:
- Publication type:
- Article
Model‐Based Prediction of Irinotecan‐Induced Grade 4 Neutropenia in Cancer Patients: Influence of Incorporating Germline Genetic Factors in the Model.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 5, p. 1162, doi. 10.1002/cpt.3190
- By:
- Publication type:
- Article
Corrections to "Effectively Leveraging RWD for External Controls: A Systematic Literature Review of Regulatory and HTA Decisions".
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 5, p. 1175, doi. 10.1002/cpt.3187
- Publication type:
- Article
Pharmacotherapy to Improve Cognitive Functioning After Acquired Brain Injury: A Meta‐Analysis and Meta‐Regression.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 5, p. 971, doi. 10.1002/cpt.3186
- By:
- Publication type:
- Article
Safety, Tolerability, and Pharmacokinetics of an Oral Small Molecule Inhibitor of IL‐17A (LY3509754): A Phase I Randomized Placebo‐Controlled Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 5, p. 1152, doi. 10.1002/cpt.3185
- By:
- Publication type:
- Article
Relationships of Proton Pump Inhibitor‐Induced Renal Injury with CYP2C19 Polymorphism: A Retrospective Cohort Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 5, p. 1141, doi. 10.1002/cpt.3183
- By:
- Publication type:
- Article
Concomitant Use of Sodium‐Glucose Cotransporter 2 Inhibitors and Overactive Bladder Drugs and the Risk of Urinary Tract Infection.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 5, p. 1132, doi. 10.1002/cpt.3182
- By:
- Publication type:
- Article
A Retrospective Analysis of the Potential Impact of Differences in Aggregates on Clinical Immunogenicity of Biosimilars and their Reference Products.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 5, p. 1122, doi. 10.1002/cpt.3180
- By:
- Publication type:
- Article
Quantitative Model‐Based Assessment of Multiple Sickle Cell Disease Therapeutic Approaches Alone and in Combination.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 5, p. 1114, doi. 10.1002/cpt.3175
- By:
- Publication type:
- Article
Population Pharmacokinetics of Pediatric Lopinavir/Ritonavir Oral Pellets in Children Living with HIV in Africa.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 5, p. 1105, doi. 10.1002/cpt.3174
- By:
- Publication type:
- Article
Model‐Based Benefit/Risk Analysis for the Copanlisib Intermittent Dosing Regimen.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 5, p. 1092, doi. 10.1002/cpt.3173
- By:
- Publication type:
- Article
Amelioration of Acute Radiation Dermatitis in Breast Cancer Patients by a Bioadhesive Barrier‐Forming Gel (Episil): A Single‐Center, Open, Parallel, Randomized, Phase I/II Controlled Trial.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 5, p. 1085, doi. 10.1002/cpt.3171
- By:
- Publication type:
- Article
A Phase I, Randomized, Multi‐Dose Study to Evaluate the Enteric Selectivity and Safety of JAK Inhibitor, Lorpucitinib, in Healthy Participants.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 5, p. 1075, doi. 10.1002/cpt.3170
- By:
- Publication type:
- Article
Summary Report of a Public Workshop: Case Studies of Multi‐Regional Clinical Trial Incorporating Concept of the ICH E17 Guideline.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 5, p. 965, doi. 10.1002/cpt.3163
- By:
- Publication type:
- Article
CYP2D6 Phenotype Influences Pharmacokinetic Parameters of Venlafaxine: Results from a Population Pharmacokinetic Model in Older Adults with Depression.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 5, p. 1065, doi. 10.1002/cpt.3162
- By:
- Publication type:
- Article
Predicting Clinical Pharmacokinetics/Pharmacodynamics and Impact of Organ Impairment on siRNA‐Based Therapeutics Using a Mechanistic Physiologically‐Based Pharmacokinetic‐Pharmacodynamic Model.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 5, p. 1054, doi. 10.1002/cpt.3160
- By:
- Publication type:
- Article
Successful Prediction of Fetal Exposure to Dual BCRP/P‐gp Drug Substrates Using the Efflux Ratio‐Relative Expression Factor Approach and PBPK M&S.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 5, p. 1044, doi. 10.1002/cpt.3157
- By:
- Publication type:
- Article
Population Pharmacokinetic Analysis of Atomoxetine and its Metabolites in Children and Adolescents with Attention‐Deficit/Hyperactivity Disorder.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 5, p. 1033, doi. 10.1002/cpt.3155
- By:
- Publication type:
- Article
Assessment of the CYP3A4 Induction Potential by Carbamazepine: Insights from Two Clinical DDI Studies and PBPK Modeling.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 5, p. 1025, doi. 10.1002/cpt.3151
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 5, p. 907, doi. 10.1002/cpt.2942
- Publication type:
- Article
Metabolite Bioanalysis in Drug Development: Recommendations from the IQ Consortium Metabolite Bioanalysis Working Group.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 5, p. 939, doi. 10.1002/cpt.3144
- By:
- Publication type:
- Article
Comparative Effectiveness of Bimekizumab in Psoriatic Arthritis: A Model‐Based Meta‐Analysis of American College of Rheumatology Response Criteria.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 5, p. 1007, doi. 10.1002/cpt.3135
- By:
- Publication type:
- Article
Circulating Tumor DNA Profiling Approach Based on In Silico Background Elimination Guides Chemotherapy in Nasopharyngeal Carcinoma.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 5, p. 993, doi. 10.1002/cpt.3125
- By:
- Publication type:
- Article
Non‐Labeled, Stable Labeled, or Radiolabelled Approaches for Provision of Intravenous Pharmacokinetics in Humans: A Discussion Piece.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 5, p. 931, doi. 10.1002/cpt.3121
- By:
- Publication type:
- Article
Implications of Incorporating Plasma Lipoprotein Binding into a Physiologically‐Based Pharmacokinetic Model: A Simulation Study with Amiodarone.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 5, p. 1015, doi. 10.1002/cpt.3149
- By:
- Publication type:
- Article